These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8784456)

  • 1. ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme.
    Gribble AD; Dolle RE; Shaw A; McNair D; Novelli R; Novelli CE; Slingsby BP; Shah VP; Tew D; Saxty BA; Allen M; Groot PH; Pearce N; Yates J
    J Med Chem; 1996 Aug; 39(18):3569-84. PubMed ID: 8784456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo.
    Gribble AD; Ife RJ; Shaw A; McNair D; Novelli CE; Bakewell S; Shah VP; Dolle RE; Groot PH; Pearce N; Yates J; Tew D; Boyd H; Ashman S; Eggleston DS; Haltiwanger RC; Okafo G
    J Med Chem; 1998 Sep; 41(19):3582-95. PubMed ID: 9733484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors.
    Li JJ; Wang H; Tino JA; Robl JA; Herpin TF; Lawrence RM; Biller S; Jamil H; Ponticiello R; Chen L; Chu CH; Flynn N; Cheng D; Zhao R; Chen B; Schnur D; Obermeier MT; Sasseville V; Padmanabha R; Pike K; Harrity T
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3208-11. PubMed ID: 17383874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
    Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
    J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076.
    Pearce NJ; Yates JW; Berkhout TA; Jackson B; Tew D; Boyd H; Camilleri P; Sweeney P; Gribble AD; Shaw A; Groot PH
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):113-9. PubMed ID: 9693110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
    Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
    J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
    Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
    J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase.
    Koerner SK; Hanai JI; Bai S; Jernigan FE; Oki M; Komaba C; Shuto E; Sukhatme VP; Sun L
    Eur J Med Chem; 2017 Jan; 126():920-928. PubMed ID: 27997879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of fatty acid binding protein in the modulation of inhibitory effect of fatty acids on fatty acid synthase and ATP-citrate lyase in developing human brain.
    Mukhopadhyay D; Mukherjea M
    Indian J Biochem Biophys; 1998 Oct; 35(5):296-302. PubMed ID: 10410463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmentation of enzymes: ATP citrate lyase in hepatocytes from fed or fasted rats.
    Cornell NW; Janski AM; Rendon A
    Fed Proc; 1985 May; 44(8):2448-52. PubMed ID: 3987919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
    Klutchko SR; Hamby JM; Boschelli DH; Wu Z; Kraker AJ; Amar AM; Hartl BG; Shen C; Klohs WD; Steinkampf RW; Driscoll DL; Nelson JM; Elliott WL; Roberts BJ; Stoner CL; Vincent PW; Dykes DJ; Panek RL; Lu GH; Major TC; Dahring TK; Hallak H; Bradford LA; Showalter HD; Doherty AM
    J Med Chem; 1998 Aug; 41(17):3276-92. PubMed ID: 9703473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel thiol-containing citric acid analogues. Kinetic evaluation of these and other potential active-site-directed and mechanism-based inhibitors of ATP citrate lyase.
    Dolle RE; Gribble A; Wilkes T; Kruse LI; Eggleston D; Saxty BA; Wells TN; Groot PH
    J Med Chem; 1995 Feb; 38(3):537-43. PubMed ID: 7853346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
    Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP citrate lyase inhibitors as novel cancer therapeutic agents.
    Zu XY; Zhang QH; Liu JH; Cao RX; Zhong J; Yi GH; Quan ZH; Pizzorno G
    Recent Pat Anticancer Drug Discov; 2012 May; 7(2):154-67. PubMed ID: 22339355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C16 and C17 substituted derivatives of pregnenolone and progesterone as inhibitors of 17alpha-hydroxylase-C17, 20-lyase: synthesis and biological evaluation.
    Haidar S; Hartmann RW
    Arch Pharm (Weinheim); 2002; 335(11-12):526-34. PubMed ID: 12596217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-citrate lyase as a target for hypolipidemic intervention. Sulfoximine and 3-hydroxy-beta-lactam containing analogues of citric acid as potential tight-binding inhibitors.
    Dolle RE; McNair D; Hughes MJ; Kruse LI; Eggelston D; Saxty BA; Wells TN; Groot PH
    J Med Chem; 1992 Dec; 35(26):4875-84. PubMed ID: 1479587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphaisocoumarins as a new class of potent inhibitors for pancreatic cholesterol esterase.
    Li B; Zhou B; Lu H; Ma L; Peng AY
    Eur J Med Chem; 2010 May; 45(5):1955-63. PubMed ID: 20149492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and hypolipidemic activity of novel 2-(m-tolyloxy) isobutyric acid derivatives.
    Idrees GA; Abuo-Rahma Gel-D; Aly OM; Radwan MF
    Eur J Med Chem; 2009 Jun; 44(6):2679-84. PubMed ID: 19121550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines.
    Traxler P; Bold G; Frei J; Lang M; Lydon N; Mett H; Buchdunger E; Meyer T; Mueller M; Furet P
    J Med Chem; 1997 Oct; 40(22):3601-16. PubMed ID: 9357527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.